5-AMINO-1MQ is a selective NNMT inhibitor belonging to the quinolinium chemical class, recognized in preclinical research for its interaction with nicotinamide metabolism and NAD+ biosynthesis pathways. This tablet formulation offers standardized dosing units for research protocols requiring oral bioavailability and pharmacokinetic assessment.

Supplied as 25 compressed tablets (50mg each), this product is intended exclusively for controlled laboratory research by qualified professionals.

Chemical Information:

• Chemical Name: 2-Methyl-5-aminoquinolinium iodide
• Molecular Formula: C10H11N2+ I-
• Molecular Weight: 159.21 g/mol (free base); MW varies with salt form
• Compound Class: Quinolinium salt; NNMT inhibitor

Research Applications:

• Pharmacokinetic profiling of oral NNMT inhibitor formulations in preclinical models
• Stability assessment of quinolinium compounds in compressed tablet matrix
• Dose-uniformity and dissolution characterization studies
• Comparative bioavailability evaluation across formulation types

Storage and Handling:

• Store at 2-8°C in a cool, dry environment protected from light
• Maintain container tightly sealed when not in use
• Handle using appropriate laboratory safety and aseptic techniques
• Use sterile, pyrogen-free water for reconstitution

Product Specifications:

• Purity: ≥99% (HPLC)
• Appearance: White to off-white tablets
• Form: Compressed tablets
• Quantity: 25 tablets × 50mg (1,250mg total)

Compliance Notice:
FOR RESEARCH USE ONLY — Not for human or veterinary consumption. This product is not a drug, food, cosmetic, or dietary supplement and has not been evaluated by the Food and Drug Administration for any purpose.